Evidence map›Paper›PMID 37171689›Full record

ArticleMagma (New York, N.Y.)2023

Ramping down a clinical 3 T scanner: a journey into MRI and MRS at 0.75 T.

Christian Guenthner, Sophie Marie Peereboom, Hannes Dillinger, Charles McGrath, Mohammed Masoud Albannay, Valery Vishnevskiy, Max Fuetterer, Roger Luechinger, Theo Jenneskens, Urs Sturzenegger and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Magma (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Cardiac MRI at Low Field Strengths.Journal of magnetic resonance imaging : JMRI · 2024
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Christian GuenthnerInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland. guenthner@biomed.ee.ethz.ch.ORCID http://orcid.org/0000-0001-8707-7016
Sophie Marie PeereboomInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
Hannes DillingerInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
Charles McGrathInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
Mohammed Masoud AlbannayInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
Valery VishnevskiyInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
Max FuettererInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
Roger LuechingerInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
Theo JenneskensPhilips Healthcare, Best, The Netherlands.
Urs SturzeneggerPhilips AG, Zurich, Switzerland.
Johan OverwegPhilips Research, Hamburg, Germany.
Peter KokenPhilips Research, Hamburg, Germany.
Peter BörnertPhilips Research, Hamburg, Germany.
Sebastian KozerkeInstitute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland.
ETH Zurich · CHPhilips (Germany) · DEPhilips (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectLower-field MR is reemerging as a viable, potentially cost-effective alternative to high-field MR, thanks to advances in hardware, sequence design, and reconstruction over the past decades. Evaluation of lower field strengths, however, is limited by the availability of lower-field systems on the market and their considerable procurement costs. In this work, we demonstrate a low-cost, temporary alternative to purchasing a dedicated lower-field MR system. MATERIALS AND

methodsBy ramping down an existing clinical 3 T MRI system to 0.75 T, proton signals can be acquired using repurposed

resultsApart from presenting system characterization results, we show in vivo examples of cardiac cine imaging, abdominal two- and three-point Dixon-type water/fat separation, water/fat-separated MR Fingerprinting, and point-resolved spectroscopy. In addition, the ramp-down approach allows unique comparisons of, e.g., gradient fidelity of the same MR system operated at different field strengths using the same receive chain, gradient coils, and amplifiers. DISCUSSION: Ramping down an existing MR system may be seen as a viable alternative for lower-field MR research in groups that already own multi-nuclei hardware and can also serve as a testing platform for custom-made multi-nuclei transmit/receive coils.

Indexed as

Magnetic Resonance ImagingSoftwareProtonsProtonsCine MRIField strengthMagnetic resonance imagingMultiparametric MRITechnology assessment

Identifiers

PMID37171689
PMCPMC10386956
OpenAlexW4376226149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.